<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-29502" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Still Disease</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bhargava</surname>
            <given-names>Juhi</given-names>
          </name>
          <aff>Medstar Washington Hospital Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Panginikkod</surname>
            <given-names>Sreelakshmi</given-names>
          </name>
          <aff>University of Massachusetts</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Juhi Bhargava declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sreelakshmi Panginikkod declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>26</day>
          <month>2</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-29502.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Adult-onset Still's disease (AOSD) is an uncommon systemic inflammatory disorder characterized by inflammatory polyarthritis, daily fever, and a transient salmon-pink maculopapular rash. A distinguishing feature is a frequently elevated serum ferritin level exceeding 1000 ng/ml. The management of AOSD underscores the pivotal role of an interprofessional healthcare team in providing comprehensive care for affected individuals.</p>
        <p>Clinicians participating in an AOSD continuing education activity can expect to gain a deep understanding of AOSD. This includes insights into its clinical presentation, diagnostic findings, and treatment options. This activity emphasizes the management of AOSD&#x000a0;and the pivotal role of an interprofessional healthcare team in delivering comprehensive care for individuals affected by this rare systemic inflammatory disorder.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the key clinical features of adult-onset Still disease during patient assessments, including inflammatory polyarthritis, daily fever, and transient salmon-pink maculopapular rash.</p></list-item><list-item><p>Select early appropriate therapeutic approaches, considering each patient's individualized needs and severity of AOSD.</p></list-item><list-item><p>Assess and monitor the efficacy of selected treatment modalities, adapting interventions based on patient response and disease progression.</p></list-item><list-item><p>Coordinate care seamlessly within the healthcare team to optimize patient outcomes, emphasizing the importance of a multidisciplinary approach in treating AOSD.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29502&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29502">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-29502.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Adult-onset Still disease (AOSD) is a rare systemic inflammatory disorder characterized by daily fever, inflammatory polyarthritis, and a transient salmon-pink maculopapular rash. Initially documented in children by&#x000a0;George Still in 1896, the term "Still disease"&#x000a0;refers to systemic juvenile idiopathic arthritis,&#x000a0;while&#x000a0;AOSD designates the condition that manifests after age 16.<xref ref-type="bibr" rid="article-29502.r1">[1]</xref></p>
      </sec>
      <sec id="article-29502.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The etiology of AOSD remains unknown. The prevailing hypothesis&#x000a0;suggests that AOSD is a reactive syndrome wherein various infectious agents may act as triggers in&#x000a0;individuals with a genetic predisposition.&#x000a0;Both genetic factors and various infectious agents, including viruses and&#x000a0;bacteria like <italic toggle="yes">Yersinia enterocolitica</italic> and <italic toggle="yes">Mycoplasma pneumoniae,</italic>&#x000a0;have been proposed as significant contributors to the development of AOSD.<xref ref-type="bibr" rid="article-29502.r2">[2]</xref><xref ref-type="bibr" rid="article-29502.r3">[3]</xref>&#x000a0;</p>
        <p>Uncertainty persists regarding the&#x000a0;uniform presence&#x000a0;of etiopathogenic factors among all AOSD patients. A French study&#x000a0;involving 62 patients&#x000a0;demonstrated an&#x000a0;association&#x000a0;between AOSD&#x000a0;and specific&#x000a0;human leukocyte antigen (HLA) subtypes (B17, B18, B35, and DR2).<xref ref-type="bibr" rid="article-29502.r4">[4]</xref>&#x000a0;Specific case reports&#x000a0;have highlighted instances of the disease occurring in twins.<xref ref-type="bibr" rid="article-29502.r5">[5]</xref></p>
      </sec>
      <sec id="article-29502.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>AOSD&#x000a0;is a very uncommon condition, with an estimated&#x000a0;annual incidence&#x000a0;ranging from&#x000a0;0.1 to 0.4 cases per 100,000 people in Europe. There is a slight predilection for females&#x000a0;over males.&#x000a0;The age distribution follows&#x000a0;a bimodal pattern, with the first peak occurring between 15&#x000a0;and 25 years and the second between 36&#x000a0;and 46. Notably, about three-quarters of patients&#x000a0;experience&#x000a0;the onset of the disease between&#x000a0;16 and 35. Although unusual, instances of onset beyond the age of 70 have also been documented.<xref ref-type="bibr" rid="article-29502.r6">[6]</xref></p>
      </sec>
      <sec id="article-29502.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Two immune dysregulations&#x000a0;play a crucial role in the&#x000a0;pathogenesis of AOSD: innate and adaptive immunity.</p>
        <p>Immunopathology in&#x000a0;innate immunity:</p>
        <list list-type="bullet">
          <list-item>
            <p>Activation of&#x000a0;neutrophils and macrophages
<list list-type="bullet"><list-item><p>Increased CXCL8 levels:
<list list-type="bullet"><list-item><p>Not correlated with disease activity</p></list-item><list-item><p>Recruits neutrophils&#x000a0;to the inflammation site</p></list-item><list-item><p>Associated with the persistence of chronic articular AOSD</p></list-item></list>
</p></list-item><list-item><p>Elevated macrophage activation markers:
<list list-type="bullet"><list-item><p>Macrophage-colony stimulating factor (M-CSF)</p></list-item><list-item><p>Calprotectin</p></list-item><list-item><p>Intracellular adhesion molecule-1 (ICAM-1)</p></list-item><list-item><p>Migration inhibitory factor (MIF)</p></list-item><list-item><p>Interferon-gamma (INF-&#x003b3;)</p></list-item></list>
</p></list-item><list-item><p>Elevated cytokines:
<list list-type="bullet"><list-item><p>Interleukin 1&#x003b2;&#x000a0;(IL-1&#x003b2;)</p></list-item><list-item><p>IL-6 in skin rash specimens and serum correlating with disease activity</p></list-item><list-item><p>IL-18 in serum, synovial fluid, liver, and lymph nodes</p></list-item><list-item><p>Tumor necrosis factor-&#x003b1; (TNF) in sera and tissues</p></list-item></list>
</p></list-item><list-item><p>Overexpression of toll-like receptor (TLR) 7-MyD88 pathway in dendritic cells:
<list list-type="bullet"><list-item><p>Correlates with disease activity and treatment</p></list-item></list>
</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>Immunopathology in adaptive immunity:</p>
        <list list-type="bullet">
          <list-item>
            <p>Increased Th1 cellular immune response
<list list-type="bullet"><list-item><p>Predominance of T cells produced by&#x000a0; IL-4T over IFN-&#x003b3; in serum, skin, and synovium compared to healthy controls&#x000a0;<xref ref-type="bibr" rid="article-29502.r7">[7]</xref></p></list-item><list-item><p>Increased &#x003b1;-soluble receptor of IL-2 (CD25)</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>Furthermore, the role of Th-17 responses is emerging in the pathogenesis of AOSD. Elevated levels of Th-17-related cytokines, including IL-1,6,17,18,21, and 23, contribute to the complex immunopathology associated with the disease.</p>
      </sec>
      <sec id="article-29502.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Three&#x000a0;primary patterns characterize the clinical course of&#x000a0;AOSD: monophasic, intermittent, and chronic.<xref ref-type="bibr" rid="article-29502.r4">[4]</xref><xref ref-type="bibr" rid="article-29502.r8">[8]</xref><xref ref-type="bibr" rid="article-29502.r9">[9]</xref>&#x000a0;Each category&#x000a0;exhibits approximately equal distribution; however, some studies suggest a higher prevalence of the chronic articular pattern. Notably, it is common for the&#x000a0;initial monophasic or intermittent patterns to evolve into a&#x000a0;chronic articular manifestation.<xref ref-type="bibr" rid="article-29502.r10">[10]</xref></p>
        <p>The&#x000a0;key clinical features&#x000a0;observed in&#x000a0;AOSD&#x000a0;include fever, rash, and arthritis or arthralgia, occurring in approximately 75% to 95% of patients.<xref ref-type="bibr" rid="article-29502.r11">[11]</xref>&#x000a0;Other common symptoms encompass myalgia, pharyngitis, lymphadenopathy, and splenomegaly. Less&#x000a0;frequently observed symptoms&#x000a0;comprise hepatomegaly, pleurisy, pericarditis, and abdominal pain.</p>
        <p>Fever&#x000a0;in AOSD usually follows a quotidian pattern (daily recurring fever with temperature returning to normal between fever spikes), often occurring late during the day and generally preceding other symptoms. The temperature can&#x000a0;fluctuate by 4 &#x000b0;C within&#x000a0;4 hours.<xref ref-type="bibr" rid="article-29502.r12">[12]</xref>&#x000a0;In approximately 20% of cases, complete defervescence&#x000a0;does not occur, fever persists between spikes, or an additional spike occurs in the morning, leading to a double quotidian fever. Sometimes, AOSD may present as a fever of unknown origin (FUO), and a temperature&#x000a0;of more than 39.5 &#x000b0;C strongly suggests a monophasic pattern.</p>
        <p>The&#x000a0;rash&#x000a0;in AOSD is classically characterized&#x000a0;as evanescent, displaying a salmon-colored, macular, or maculopapular appearance. It is usually nonpruritic and tends to coincide with the onset of fever.&#x000a0;While primarily observed on the&#x000a0;trunk and extremities, the rash can manifest on the palms, soles, and face. The rash can sometimes be induced by heat (hot shower or towel) or skin friction, known as the Koebner phenomenon.</p>
        <p>Arthritis in AOSD may&#x000a0;initially present as mild, transient, and oligoarticular, potentially progressing into severe, destructive, and symmetric polyarticular forms.<xref ref-type="bibr" rid="article-29502.r1">[1]</xref>&#x000a0;Predominantly affected joints are the knees, wrists, and ankles, although elbows, proximal interphalangeal joints, shoulders, metacarpophalangeal, metatarsophalangeal, hips, distal interphalangeal, and temporomandibular joints can also be involved. Fusion of the wrist joint is characteristic of AOSD but is&#x000a0;observed in only a few patients.</p>
        <p>Myalgia&#x000a0;tends to exacerbate during&#x000a0;fever spikes and can occasionally be severe and debilitating. Muscle weakness is not a typical feature,&#x000a0;although case reports have&#x000a0;indicated a slight elevation of serum creatine kinase and aldolase levels. Electromyographic studies and muscle biopsies are typically either normal or may show nonspecific findings associated with inflammatory myopathy.</p>
        <p>Patients&#x000a0;with AOSD may&#x000a0;present with a sore throat during the initial evaluation, which frequently recurs during disease flares. In such cases, examination typically reveals severe, nonsuppurative pharyngitis, and&#x000a0;bacterial cultures are generally negative. A review of 341 cases of AOSD&#x000a0;reported a sore throat in 69% of the patients.<xref ref-type="bibr" rid="article-29502.r13">[13]</xref>&#x000a0;</p>
        <p>Symmetrical slightly tender lymphadenopathy is reported in one-third to two-thirds of patients with AOSD,&#x000a0;while splenomegaly&#x000a0;is observed in one-third to one-half of patients. Liver abnormalities&#x000a0;encompass hepatomegaly ranging from 12% to 45%&#x000a0;and, more commonly, modest elevations of serum hepatic transaminases and alkaline phosphatase levels. About 30% to 40% of patients with AOSD&#x000a0;may experience pericarditis, pleural effusions, and transient pulmonary infiltrates.<xref ref-type="bibr" rid="article-29502.r10">[10]</xref><xref ref-type="bibr" rid="article-29502.r11">[11]</xref><xref ref-type="bibr" rid="article-29502.r14">[14]</xref>&#x000a0;</p>
        <p>Macrophage activation syndrome (MAS)&#x000a0;occurs in a small minority of patients with AOSD, potentially underdiagnosed, as&#x000a0;indicated by retrospective studies&#x000a0;reporting&#x000a0;MAS occurred in&#x000a0;6 out of 50 patients and 21 out of 109 patients. Unlike AOSD, patients with MAS may&#x000a0;exhibit&#x000a0;markedly&#x000a0;elevated levels of serum triglycerides, along with normal or low haptoglobin and fibrinogen, and may experience leukopenia&#x000a0;and&#x000a0;thrombocytopenia.<xref ref-type="bibr" rid="article-29502.r15">[15]</xref><xref ref-type="bibr" rid="article-29502.r16">[16]</xref>&#x000a0;Abdominal pain&#x000a0;is reported in 1% to 48% of the patients, and additional symptoms such as nausea, anorexia, lymphadenitis, aseptic or acute pancreatitis, and weight loss can also occur.</p>
      </sec>
      <sec id="article-29502.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The lab findings discussed below are characteristic of AOSD but&#x000a0;are not pathognomonic. Therefore, their presence,&#x000a0;in conjunction with clinical manifestations, assists the clinician in establishing the diagnosis after ruling out alternate causes.</p>
        <p>Ferritin levels typically exceed five times the upper limits of normal in patients&#x000a0;with AOSD. An elevated ferritin level indicates the presence&#x000a0;of the disease with an 80% sensitivity and 46% specificity.&#x000a0;When coupled with a decrease in the proportion of glycosylated ferritin (&#x0003c;20%), the specificity&#x000a0;increases&#x000a0;to 93%. Ferritin levels&#x000a0;are also monitored during treatment.<xref ref-type="bibr" rid="article-29502.r17">[17]</xref></p>
        <p>In almost all patients, inflammatory markers such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) are elevated.<xref ref-type="bibr" rid="article-29502.r4">[4]</xref>&#x000a0;Hematological findings include leukocytosis, typically&#x000a0;exceeding 15,000 cells per microliter with a predominant neutrophil count greater than 80%, normocytic normochromic anemia, and thrombocytosis. These hematological abnormalities can be severe enough to mimic primary hematologic disease, and in some instances, red cell aplasia has been observed.<xref ref-type="bibr" rid="article-29502.r18">[18]</xref></p>
        <p>Bone marrow biopsy reports have indicated hyperplasia of granulocytic precursors, and hypercellularity and hemophagocytosis have been observed in some cases. Hepatic transaminases can be elevated in 75% of patients, and elevated aldolase levels can also&#x000a0;occur, attributed to liver inflammation.</p>
        <p>In less than 10% of patients, antinuclear antibodies (ANA) and rheumatoid factor (RF) are detected, typically in low titers. The scarcity of these autoantibodies underscores the importance of considering additional diagnostic factors and clinical manifestations for a thorough evaluation in establishing a comprehensive diagnosis of AOSD.</p>
        <p>The synovial fluid&#x000a0;typically exhibits&#x000a0;signs of inflammation, with a mean leukocyte range of 100 to 48,000 cells per microliter.<xref ref-type="bibr" rid="article-29502.r4">[4]</xref>&#x000a0;Furthermore, inflammatory markers in the synovial fluid underscore the systemic nature of&#x000a0;AOSD and guide clinicians in tailoring appropriate therapeutic interventions.</p>
        <p>Radiographs in the early stages of the disease are typically either normal or may&#x000a0;reveal slight joint space narrowing or periarticular osteopenia.<xref ref-type="bibr" rid="article-29502.r4">[4]</xref>&#x000a0;A classic radiographic finding of AOSD involves narrowing the wrist carpometacarpal and intercarpal joint spaces, which may progress to bone ankylosis.<xref ref-type="bibr" rid="article-29502.r19">[19]</xref><xref ref-type="bibr" rid="article-29502.r20">[20]</xref></p>
        <p>Computed tomography (CT) and&#x000a0;F-fluorodeoxyglucose positron emission tomography (FDG-PET) can detect abnormalities, revealing lymph node enlargement, splenomegaly, pulmonary abnormalities, and&#x000a0;hepatomegaly.&#x000a0;These imaging modalities play a crucial role in assessing the extent of systemic involvement and contribute to a comprehensive diagnostic evaluation.</p>
        <p>The following&#x000a0;additional tests&#x000a0;can also be&#x000a0;conducted to establish the diagnosis:</p>
        <list list-type="bullet">
          <list-item>
            <p>Complete blood count (CBC) with differential and platelet count</p>
          </list-item>
          <list-item>
            <p>ANA, RF, and anti-citrullinated peptide (anti-CCP) antibody testing</p>
          </list-item>
          <list-item>
            <p>Blood cultures</p>
          </list-item>
          <list-item>
            <p>Liver enzymes, including bilirubin, aminotransferase, alkaline phosphatase, and serum albumin</p>
          </list-item>
          <list-item>
            <p>Serologic testing for hepatitis B and C, Epstein Barr virus, and human parvovirus B19; and testing for&#x000a0;HIV</p>
          </list-item>
          <list-item>
            <p>Plain radiographs of the chest</p>
          </list-item>
          <list-item>
            <p>Blood urea nitrogen (BUN), creatinine</p>
          </list-item>
          <list-item>
            <p>Urinalysis with microscopic examination and urine culture</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-29502.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The therapeutic objects include&#x000a0;managing symptoms, physical signs, and laboratory markers of inflammation.&#x000a0;Additionally, the goals&#x000a0;involve preventing end-organ damage and&#x000a0;minimizing&#x000a0;the long-term effects of therapy.</p>
        <p>The&#x000a0;effectiveness&#x000a0;of treatment interventions for AOSD is derived from observational studies and clinical experience.<xref ref-type="bibr" rid="article-29502.r8">[8]</xref><xref ref-type="bibr" rid="article-29502.r10">[10]</xref>&#x000a0;Initial therapeutic decisions are&#x000a0;guided by&#x000a0;the degree of disease activity,&#x000a0;with&#x000a0;subsequent&#x000a0;decisions informed by the&#x000a0;clinical response.</p>
        <p>Mild disease&#x000a0;presentation in AOSD is characterized by symptoms such as&#x000a0;fevers, rash, arthralgia, or mild arthritis. While some patients with mild disease may respond to nonsteroidal anti-inflammatory drugs (NSAIDs) alone, most&#x000a0;benefit from at least a low dose of glucocorticoid for better control. Typical choices include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Naproxen&#x000a0;500 mg twice daily</p>
          </list-item>
          <list-item>
            <p>Indomethacin&#x000a0;25 to 50 mg&#x000a0;3 times daily</p>
          </list-item>
          <list-item>
            <p>Ibuprofen&#x000a0;800 mg&#x000a0;3 times daily</p>
          </list-item>
        </list>
        <p>Moderate disease&#x000a0;presentation in AOSD is marked by&#x000a0;debilitating joint symptoms, high-grade fever, or internal organ involvement&#x000a0;that is not life-threatening. In contrast,&#x000a0;severe disease&#x000a0;involves life-threatening organ&#x000a0;complications like cardiac tamponade, disseminated intravascular involvement, or severe hepatic involvement. Patients with moderate to severe disease are&#x000a0;managed as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Anakinra is&#x000a0;favored&#x000a0;as the initial agent in patients without joint erosions,&#x000a0;while methotrexate is preferred in patients with prevalent joint disease. The initial&#x000a0;dose is 100 mg&#x000a0;administered&#x000a0;subcutaneously daily,&#x000a0;with the option to&#x000a0;increase to 100 mg twice daily if a partial response is observed within&#x000a0;2 weeks.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Glucocorticoids&#x000a0;serve as&#x000a0;the second-line treatment after anakinra, typically at a dose of prednisone 20 to 60 mg orally. In some instances, intraarticular steroids&#x000a0;may be considered, and a pulse dose of methylprednisolone 100 mg daily for up to three days is used in patients with&#x000a0;MAS or those with refractory systemic or arthritic disease.<xref ref-type="bibr" rid="article-29502.r21">[21]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Limited evidence suggests that canakinumab, rilonacept, rituximab, and abatacept may effectively treat patients refractory to other therapies.</p>
          </list-item>
        </list>
        <p>Patients should&#x000a0;undergo regular monitoring, including periodic assessments of CBC,&#x000a0;BUN, creatinine, electrolytes, ferritin, D-dimer, alanine transaminase (ALT), and aspartate<bold>&#x000a0;</bold>aminotransferase (AST).</p>
        <p>Most&#x000a0;patients with AOSD eventually&#x000a0;achieve the ability&#x000a0;to&#x000a0;discontinue therapy.&#x000a0;Some may experience a&#x000a0;monocyclic form of AOSD. There are no&#x000a0;established&#x000a0;protocols for tapering and discontinuing disease-modifying antirheumatic drugs.</p>
        <p>For patients in complete remission for at least&#x000a0;3 months, the recommended approach is to taper medications to discontinue all drugs gradually. Regular monitoring during tapering contributes to individualized management for each patient with AOSD.</p>
      </sec>
      <sec id="article-29502.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The accurate diagnosis of AOSD relies on a thorough evaluation of clinical, laboratory, and imaging findings to differentiate&#x000a0;it from its diverse array of potential mimickers. The broad differential encompasses&#x000a0;infections, malignancy, rheumatologic disorders, and adverse drug reactions.</p>
        <p>Among infectious etiologies,&#x000a0;several acute viral infections, including parvovirus B19, hepatitis, and others,&#x000a0;can&#x000a0;produce symptoms similar to AOSD. Bacteremia can also cause fever, elevated white blood cell (WBC) count, and acute phase reactants.</p>
        <p>Among rheumatologic diseases, systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and reactive arthritis can also cause elevation of acute phase reactants. Vasculitic disorders, like polyarteritis nodosa (PAN), presenting with fever, arthralgia, skin lesions, and abdominal pain,&#x000a0;may also mimic AOSD.</p>
        <p>Malignancy, especially lymphomas,&#x000a0;can mimic AOSD due to shared features of lymphadenopathy, fever, and leukocytosis.</p>
      </sec>
      <sec id="article-29502.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The course of AOSD generally&#x000a0;aligns with&#x000a0;1 of 3 patterns: self-limited illness, intermittent flares, or chronic Still disease. Predictors for chronicity and unfavorable outcomes include the presence of erosive polyarthritis at the time of presentation and involvement of shoulders or hips.<xref ref-type="bibr" rid="article-29502.r4">[4]</xref><xref ref-type="bibr" rid="article-29502.r12">[12]</xref><xref ref-type="bibr" rid="article-29502.r22">[22]</xref>&#x000a0;Additionally, the need for systemic glucocorticoids for more than&#x000a0;2 years before routine use of biologics is also considered a poor prognostic marker.</p>
      </sec>
      <sec id="article-29502.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of AOSD&#x000a0;include MAS, amyloidosis, disseminated intravascular coagulopathy (DIC), pulmonary arterial hypertension (PAH), thrombotic thrombocytopenic purpura (TTP), and diffuse alveolar hemorrhage. Timely recognizing and managing these complications is crucial in optimizing patient outcomes and minimizing potential long-term sequelae.</p>
      </sec>
      <sec id="article-29502.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>In managing AOSD, healthcare professionals must foster a collaborative relationship with patients to optimize prevention and care. Early recognition plays a pivotal role; thus, patients should be educated on the hallmark signs and symptoms of AOSD, including persistent fevers, rash, and joint pain. Encourage patients to seek prompt medical attention if they experience such manifestations. Regular monitoring through scheduled check-ups and appropriate diagnostic tests is imperative to track disease progression and adjust treatment plans accordingly. Medication adherence, stressing the significance of following prescribed regimens meticulously, should be emphasized.</p>
        <p>Reinforced lifestyle choices supporting overall well-being, such as maintaining a healthy diet and engaging in regular exercise, are necessary. Patient education is a cornerstone, empowering individuals with knowledge about AOSD, treatment options, and potential complications. Access to support networks and connecting patients with relevant organizations and support groups should be facilitated. Additionally, highlighting the role of emotional well-being and encouraging patients to prioritize mental health and seek appropriate support is paramount. Ultimately, the collaborative efforts between healthcare professionals and patients are instrumental in navigating the complexities of AOSD management effectively.</p>
      </sec>
      <sec id="article-29502.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Key facts to keep in mind about AOSD are as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>AOSD exhibits a variable course, ranging from self-limiting episodes to chronic and debilitating conditions.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Multiple systems can be involved, including joints, skin, and internal organs.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Elevated ferritin levels, often exceeding five times the upper limits of normal, serve as a critical marker in diagnosing and monitoring AOSD.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Treatment strategies may involve NSAIDs, steroids, and biologics tailored to disease severity.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>AOSD can mimic various infectious, rheumatologic, and neoplastic conditions, necessitating careful consideration of differential diagnoses.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Vigilant monitoring for complications such as&#x000a0;MAS and cardiovascular involvement is essential for optimal patient care.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-29502.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>AOSD&#x000a0;is, in part, a diagnosis of exclusion and frequently&#x000a0;presents a diagnostic challenge. While a rheumatologist&#x000a0;typically leads the care team, collaboration with specialists such as cardiologists, gastroenterologists, and oncologists&#x000a0;is crucial&#x000a0;for comprehensive management. The disease can cause complications in multiple organ systems, necessitating a multidisciplinary approach. As integral members of the healthcare team, nurses play a vital role in monitoring vital signs, administering medications, and alerting clinicians&#x000a0;to&#x000a0;changes in patient status or lack of progress, contributing significantly to the overall patient care strategy.</p>
        <p>Due to&#x000a0;the severe joint involvement in AOSD, physical and occupational therapy&#x000a0;are essential components of the&#x000a0;patient's rehabilitation regimen.&#x000a0;Given the&#x000a0;potential for&#x000a0;life-threatening complications, a detailed history and physical examination are&#x000a0;imperative when&#x000a0;AOSD is suspected. This approach is crucial for early detection, preventing complications, and improving the overall prognosis.<xref ref-type="bibr" rid="article-29502.r23">[23]</xref></p>
      </sec>
      <sec id="article-29502.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29502&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29502">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/arthritis/still-disease/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=29502">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/29502/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=29502">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-29502.s16">
        <title>References</title>
        <ref id="article-29502.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elkon</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Hughes</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Bywaters</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Ryan</surname>
                <given-names>PF</given-names>
              </name>
              <name>
                <surname>Inman</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Bowley</surname>
                <given-names>NB</given-names>
              </name>
              <name>
                <surname>James</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Eady</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Adult-onset Still's disease. Twenty-year followup and further studies of patients with active disease.</article-title>
            <source>Arthritis Rheum</source>
            <year>1982</year>
            <month>Jun</month>
            <volume>25</volume>
            <issue>6</issue>
            <fpage>647</fpage>
            <page-range>647-54</page-range>
            <pub-id pub-id-type="pmid">7092964</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29502.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ohta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yamaguchi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tsunematsu</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kasukawa</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mizushima</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kashiwagi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kashiwazaki</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tanimoto</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Matsumoto</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Akizuki</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Adult Still's disease: a multicenter survey of Japanese patients.</article-title>
            <source>J Rheumatol</source>
            <year>1990</year>
            <month>Aug</month>
            <volume>17</volume>
            <issue>8</issue>
            <fpage>1058</fpage>
            <page-range>1058-63</page-range>
            <pub-id pub-id-type="pmid">2213780</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29502.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Colebunders</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Stevens</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Vanagt</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Snoeck</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Adult Still's disease caused by Yersinia enterocolitica infection.</article-title>
            <source>Arch Intern Med</source>
            <year>1984</year>
            <month>Sep</month>
            <volume>144</volume>
            <issue>9</issue>
            <fpage>1880</fpage>
            <page-range>1880-2</page-range>
            <pub-id pub-id-type="pmid">6477013</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29502.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pouchot</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sampalis</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Beaudet</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Carette</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>D&#x000e9;cary</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Salusinsky-Sternbach</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>RO</given-names>
              </name>
              <name>
                <surname>Gutkowski</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Harth</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Myhal</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Adult Still's disease: manifestations, disease course, and outcome in 62 patients.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>1991</year>
            <month>Mar</month>
            <volume>70</volume>
            <issue>2</issue>
            <fpage>118</fpage>
            <page-range>118-36</page-range>
            <pub-id pub-id-type="pmid">2005777</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29502.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kahn</surname>
                <given-names>MF</given-names>
              </name>
            </person-group>
            <article-title>Adult Still's disease. Still many issues unresolved.</article-title>
            <source>J Rheumatol</source>
            <year>1996</year>
            <month>Dec</month>
            <volume>23</volume>
            <issue>12</issue>
            <fpage>2015</fpage>
            <page-range>2015-6</page-range>
            <pub-id pub-id-type="pmid">8970032</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29502.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Uson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pe&#x000f1;a</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>del Arco</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Barbado</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Vazquez</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Still's disease in a 72-year-old man.</article-title>
            <source>J Rheumatol</source>
            <year>1993</year>
            <month>Sep</month>
            <volume>20</volume>
            <issue>9</issue>
            <fpage>1608</fpage>
            <page-range>1608-9</page-range>
            <pub-id pub-id-type="pmid">8164226</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29502.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>DY</given-names>
              </name>
              <name>
                <surname>Lan</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Hsieh</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Wen</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still's disease.</article-title>
            <source>Ann Rheum Dis</source>
            <year>2004</year>
            <month>Oct</month>
            <volume>63</volume>
            <issue>10</issue>
            <fpage>1300</fpage>
            <page-range>1300-6</page-range>
            <pub-id pub-id-type="pmid">15361391</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29502.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kontzias</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Efthimiou</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Adult-onset Still's disease: pathogenesis, clinical manifestations and therapeutic advances.</article-title>
            <source>Drugs</source>
            <year>2008</year>
            <volume>68</volume>
            <issue>3</issue>
            <fpage>319</fpage>
            <page-range>319-37</page-range>
            <pub-id pub-id-type="pmid">18257609</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29502.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gerfaud-Valentin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Maucort-Boulch</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hot</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Iwaz</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ninet</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Durieu</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Broussolle</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>S&#x000e8;ve</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Adult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>93</volume>
            <issue>2</issue>
            <fpage>91</fpage>
            <page-range>91-99</page-range>
            <pub-id pub-id-type="pmid">24646465</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29502.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fautrel</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Adult-onset Still disease.</article-title>
            <source>Best Pract Res Clin Rheumatol</source>
            <year>2008</year>
            <month>Oct</month>
            <volume>22</volume>
            <issue>5</issue>
            <fpage>773</fpage>
            <page-range>773-92</page-range>
            <pub-id pub-id-type="pmid">19028363</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29502.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gerfaud-Valentin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jamilloux</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Iwaz</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>S&#x000e8;ve</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Adult-onset Still's disease.</article-title>
            <source>Autoimmun Rev</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>13</volume>
            <issue>7</issue>
            <fpage>708</fpage>
            <page-range>708-22</page-range>
            <pub-id pub-id-type="pmid">24657513</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29502.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Calabro</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Marchesano</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Fever associated with juvenile rheumatoid arthritis.</article-title>
            <source>N Engl J Med</source>
            <year>1967</year>
            <month>Jan</month>
            <day>05</day>
            <volume>276</volume>
            <issue>1</issue>
            <fpage>11</fpage>
            <page-range>11-8</page-range>
            <pub-id pub-id-type="pmid">6015551</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29502.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nguyen</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Weisman</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Severe sore throat as a presenting symptom of adult onset Still's disease: a case series and review of the literature.</article-title>
            <source>J Rheumatol</source>
            <year>1997</year>
            <month>Mar</month>
            <volume>24</volume>
            <issue>3</issue>
            <fpage>592</fpage>
            <page-range>592-7</page-range>
            <pub-id pub-id-type="pmid">9058672</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29502.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cheema</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Quismorio</surname>
                <given-names>FP</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary involvement in adult-onset Still's disease.</article-title>
            <source>Curr Opin Pulm Med</source>
            <year>1999</year>
            <month>Sep</month>
            <volume>5</volume>
            <issue>5</issue>
            <fpage>305</fpage>
            <page-range>305-9</page-range>
            <pub-id pub-id-type="pmid">10461535</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29502.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bae</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Jung</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Suh</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features, predictive factors, and prognosis in 21 patients.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>94</volume>
            <issue>4</issue>
            <fpage>e451</fpage>
            <pub-id pub-id-type="pmid">25634183</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29502.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arlet</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Le</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Marinho</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Amoura</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Wechsler</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Papo</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Piette</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature.</article-title>
            <source>Ann Rheum Dis</source>
            <year>2006</year>
            <month>Dec</month>
            <volume>65</volume>
            <issue>12</issue>
            <fpage>1596</fpage>
            <page-range>1596-601</page-range>
            <pub-id pub-id-type="pmid">16540551</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29502.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Van Reeth</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Le Moel</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lasne</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Revenant</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Agneray</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kahn</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Bourgeois</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Serum ferritin and isoferritins are tools for diagnosis of active adult Still's disease.</article-title>
            <source>J Rheumatol</source>
            <year>1994</year>
            <month>May</month>
            <volume>21</volume>
            <issue>5</issue>
            <fpage>890</fpage>
            <page-range>890-5</page-range>
            <pub-id pub-id-type="pmid">8064731</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29502.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chung</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Suh</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Suh</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>Pure red cell aplasia and adult-onset Still's disease.</article-title>
            <source>Clin Rheumatol</source>
            <year>2004</year>
            <month>Aug</month>
            <volume>23</volume>
            <issue>4</issue>
            <fpage>368</fpage>
            <page-range>368-70</page-range>
            <pub-id pub-id-type="pmid">15293104</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29502.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Medsger</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Christy</surname>
                <given-names>WC</given-names>
              </name>
            </person-group>
            <article-title>Carpal arthritis with ankylosis in late onset Still's disease.</article-title>
            <source>Arthritis Rheum</source>
            <year>1976</year>
            <season>Mar-Apr</season>
            <volume>19</volume>
            <issue>2</issue>
            <fpage>232</fpage>
            <page-range>232-42</page-range>
            <pub-id pub-id-type="pmid">1259802</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29502.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bj&#x000f6;rkengren</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Pathria</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Sartoris</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Terkeltaub</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Esdaile</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Weisman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Resnick</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Carpal alterations in adult-onset Still disease, juvenile chronic arthritis, and adult-onset rheumatoid arthritis: comparative study.</article-title>
            <source>Radiology</source>
            <year>1987</year>
            <month>Nov</month>
            <volume>165</volume>
            <issue>2</issue>
            <fpage>545</fpage>
            <page-range>545-8</page-range>
            <pub-id pub-id-type="pmid">3659381</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29502.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khraishi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fam</surname>
                <given-names>AG</given-names>
              </name>
            </person-group>
            <article-title>Treatment of fulminant adult Still's disease with intravenous pulse methylprednisolone therapy.</article-title>
            <source>J Rheumatol</source>
            <year>1991</year>
            <month>Jul</month>
            <volume>18</volume>
            <issue>7</issue>
            <fpage>1088</fpage>
            <page-range>1088-90</page-range>
            <pub-id pub-id-type="pmid">1920313</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29502.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wouters</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>van der Veen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>van de Putte</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>de Rooij</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Adult onset Still's disease and viral infections.</article-title>
            <source>Ann Rheum Dis</source>
            <year>1988</year>
            <month>Sep</month>
            <volume>47</volume>
            <issue>9</issue>
            <fpage>764</fpage>
            <page-range>764-7</page-range>
            <pub-id pub-id-type="pmid">3178317</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29502.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Agha-Abbaslou</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bensaci</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Dike</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Poznansky</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Hyat</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Adult-Onset Still's Disease: Still a Serious Health Problem (a Case Report and Literature Review).</article-title>
            <source>Am J Case Rep</source>
            <year>2017</year>
            <month>Feb</month>
            <day>03</day>
            <volume>18</volume>
            <fpage>119</fpage>
            <page-range>119-124</page-range>
            <pub-id pub-id-type="pmid">28154368</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
